These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3339950)

  • 1. The intrinsic activity of (-)-3-PPP (preclamol) on pituitary DA receptors in female rats is enhanced following chronic DA depletion.
    Carlsson M; Eriksson E
    Life Sci; 1988; 42(5):585-8. PubMed ID: 3339950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intrinsic activities of the partial dopamine receptor agonists (-)-3-PPP and TDHL on pituitary dopamine receptors are lower in female than in male rats.
    Carlsson M; Carlsson A; Eriksson E
    Eur J Pharmacol; 1987 Oct; 142(1):39-43. PubMed ID: 3691635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective inhibition of prolactin secretion by (-)-HW-165, a novel 3-PPP congener; further support for similarities between central DA autoreceptors and pituitary lactotroph DA receptors.
    Hjorth S; Eriksson E; Andersson B
    Eur J Pharmacol; 1986 Jun; 125(3):421-8. PubMed ID: 3755402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The enhanced responsiveness of hypophyseal DA receptors in female rats induced by repeated reserpine treatment is not due to decreased oestrogen secretion.
    Carlsson M; Eriksson E
    Pharmacol Toxicol; 1989 Sep; 65(3):236-8. PubMed ID: 2813297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexually differentiated actions of 3-PPP enantiomers on prolactin secretion.
    Carlsson M; Eriksson E; Nilsson C; Carlsson A
    Neuropharmacology; 1986 Aug; 25(8):951-4. PubMed ID: 3774120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine receptors involved in prolactin secretion pharmacologically characterized by means of 3-PPP enantiomers.
    Eriksson E; Modigh K; Carlsson A; Wikström H
    Eur J Pharmacol; 1983 Dec; 96(1-2):29-36. PubMed ID: 6662196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine (DA) autoreceptor efficacy of 3-PPP enantiomers after short-term synaptic DA deprivation.
    Hjorth S; Clark D; Carlsson A
    Eur J Pharmacol; 1988 Aug; 152(3):207-15. PubMed ID: 3146512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the two partial D2 agonists (+)- and (-)-3-PPP on prolactin release in EEDQ treated male rats.
    Ekman A; Quiding M; Eriksson E
    Life Sci; 1991; 48(4):311-20. PubMed ID: 1671291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of two dopamine agonists, TL-99 and 3-PPP, on prolactin secretion in the rat.
    Gudelsky GA; Passaro E; Meltzer HY
    Eur J Pharmacol; 1983 Jun; 90(4):423-5. PubMed ID: 6884430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The partial dopamine receptor agonists (--)-3-PPP and transdihydrolisuride enhance prolactin secretion in female but not in male rats.
    Carlsson M; Eriksson E
    J Neural Transm; 1989; 77(2-3):211-6. PubMed ID: 2569498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of (+)- and (-)-3-PPP with the dopamine receptor in the anterior pituitary gland.
    Mikuni M; Gudelsky GA; Simonovic M; Meltzer HY
    Life Sci; 1984 Jan; 34(3):239-46. PubMed ID: 6694521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptor agonists: intrinsic activity vs. state of receptor.
    Carlsson A
    J Neural Transm; 1983; 57(4):309-15. PubMed ID: 6418858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J
    Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat.
    Andersson K; Fuxe K; Eneroth P; Härfstrand A; Agnati LF
    Neuroendocrinology; 1988 Aug; 48(2):188-200. PubMed ID: 2975769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of pulsatile LH secretion, pituitary GnRH receptor content and pituitary responsiveness to GnRH by hyperprolactinemia in the male rat.
    Fox SR; Hoefer MT; Bartke A; Smith MS
    Neuroendocrinology; 1987 Oct; 46(4):350-9. PubMed ID: 2823160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.
    Shah GV; Shyr SW; Grosvenor CE; Crowley WR
    Endocrinology; 1988 May; 122(5):1883-9. PubMed ID: 3129278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations.
    Clark D; Hjorth S; Carlsson A
    J Neural Transm; 1985; 62(3-4):171-207. PubMed ID: 2863323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP.
    Hjorth S; Carlsson A; Clark D; Svensson K; Wikström H; Sanchez D; Lindberg P; Hacksell U; Arvidsson LE; Johansson A
    Psychopharmacology (Berl); 1983; 81(2):89-99. PubMed ID: 6415751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats.
    Rung JP; Rung E; Johansson AM; Svensson K; Carlsson A; Carlsson ML
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jul; 384(1):39-45. PubMed ID: 21533991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
    Clark D; Salah RS; Galloway MP
    Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.